Miraomics

Attention Early-Stage Biotech Companies!

Do you have cutting-edge technology to develop new therapeutic agents—leveraging AI to create small molecules or biologics faster, cheaper, and more effectively than your competition? Now, you’re at a crossroads: selecting the right target and indication to drive your next phase of development and secure additional funding.

To stand out to investors, you need a solid data package that answers two key questions:

  1. Why this indication? What’s the rationale behind your choice of disease area?
  2. Why this target? What makes it a safe and promising target for therapy?

This isn’t easy. Consider B-cell lymphoma alone: the list of clinically pursued surface targets exceeds 10 (as shown in this review. For triple-negative breast cancer (TNBC), according to this review, the number of relevant targets skyrockets to over 25. When you include small molecule targets and repurposing candidates across many oncologic indications, the potential target list expands into the hundreds. What’s fascinating is that many of these targets seem plausible, backed by multiple lines of evidence. But as a small company, you need to narrow this down to the top five. So, how do you even begin?

That’s where we come in.

As a professional services firm, we specialize in helping biotech companies like yours make smart, strategic decisions using our proven multi-omic methodology. Whether you’re looking for targets in common or rare indications, we tailor our approach to your unique technology and goals.

  • We identify targets—intracellular, extracellular, secreted, or otherwise—whether they’re well-characterized or novel and patent-clear.
  • We go beyond targets to identify cell types, pathways, and other biological properties that could drive your success.
  • No data? No problem. Our large, curated multi-omic database often allows us to find a path forward without the need for expensive proprietary data—or to help you identify exactly what data you should generate.

Reach out today for a free 30-minute consultation to discuss your project, and request an example case study to see how we can help. Let us simplify your decision-making process and give you the insights needed to move forward with confidence!